| # | Drug | Count |
|---|---|---|
| 0 | MOXIFLOXACIN HYDROCHLORIDE | 49 |
| 1 | DEXAMETHASONE | 42 |
| 2 | DEXAMETHASONE 1.5 MG | 36 |
| 3 | VORICONAZOLE | 35 |
| 4 | VORICONAZOLE INJECTION | 34 |
| 5 | MOXIFLOXACIN | 33 |
| 6 | OFLOXACIN | 32 |
| 7 | OFLOXACIN OPHTHALMIC SOLUTION USP, 0.3% | 30 |
| 8 | OFLOXACIN OTIC | 30 |
| 9 | OFLOXACIN OTIC SOLUTION | 30 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND BACITRACIN ZINC | 1 | 0.0769 |
| 1 | NATAMYCIN | 7 | 0.0171 |
| 2 | NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE | 1 | 0.0049 |
| 3 | OFLOXACIN | 32 | 0.0044 |
| 4 | OFLOXACIN OTIC SOLUTION | 30 | 0.0043 |
| 5 | OFLOXACIN OPHTHALMIC SOLUTION USP, 0.3% | 30 | 0.0043 |
| 6 | OFLOXACIN OTIC | 30 | 0.0042 |
| 7 | FLUOROMETHOLONE ACETATE | 1 | 0.0037 |
| 8 | MINERAL OIL, WHITE PETROLATUM | 1 | 0.0035 |
| 9 | GATIFLOXACIN | 6 | 0.0034 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 107 |
| 1 | Azole Antifungal [EPC] | 39 |
| 2 | Quinolone Antimicrobial [EPC] | 37 |
| 3 | Aminoglycoside Antibacterial [EPC] | 25 |
| 4 | Fluoroquinolone Antibacterial [EPC] | 22 |
| 5 | Lipid-based Polyene Antifungal [EPC] | 17 |
| 6 | Polyene Antifungal [EPC] | 17 |
| 7 | Tetracycline-class Drug [EPC] | 15 |
| 8 | Anticholinergic [EPC] | 12 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 11 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Polyene Antimicrobial [EPC] | 7 | 0.0171 |
| 1 | Quinolone Antimicrobial [EPC] | 37 | 0.0037 |
| 2 | Lipid-based Polyene Antifungal [EPC] | 17 | 0.0013 |
| 3 | Plasma Volume Expander [EPC] | 3 | 0.0010 |
| 4 | Anticholinergic [EPC] | 12 | 0.0007 |
| 5 | Aminoglycoside Antibacterial [EPC] | 25 | 0.0006 |
| 6 | Polyene Antifungal [EPC] | 17 | 0.0004 |
| 7 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 7 | 0.0003 |
| 8 | Cholinergic Muscarinic Antagonist [EPC] | 10 | 0.0003 |
| 9 | Azole Antifungal [EPC] | 39 | 0.0002 |